Unknown

Dataset Information

0

Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.


ABSTRACT: Oxicams are widely used nonsteroidal anti-inflammatory drugs (NSAIDs), but little is known about the molecular basis of the interaction with their target enzymes, the cyclooxygenases (COX). Isoxicam is a nonselective inhibitor of COX-1 and COX-2 whereas meloxicam displays some selectivity for COX-2. Here we report crystal complexes of COX-2 with isoxicam and meloxicam at 2.0 and 2.45 angstroms, respectively, and a crystal complex of COX-1 with meloxicam at 2.4 angstroms. These structures reveal that the oxicams bind to the active site of COX-2 using a binding pose not seen with other NSAIDs through two highly coordinated water molecules. The 4-hydroxyl group on the thiazine ring partners with Ser-530 via hydrogen bonding, and the heteroatom of the carboxamide ring of the oxicam scaffold interacts with Tyr-385 and Ser-530 through a highly coordinated water molecule. The nitrogen atom of the thiazine and the oxygen atom of the carboxamide bind to Arg-120 and Tyr-355 via another highly ordered water molecule. The rotation of Leu-531 in the structure opens a novel binding pocket, which is not utilized for the binding of other NSAIDs. In addition, a detailed study of meloxicam·COX-2 interactions revealed that mutation of Val-434 to Ile significantly reduces inhibition by meloxicam due to subtle changes around Phe-518, giving rise to the preferential inhibition of COX-2 over COX-1.

SUBMITTER: Xu S 

PROVIDER: S-EPMC3945341 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.

Xu Shu S   Hermanson Daniel J DJ   Banerjee Surajit S   Ghebreselasie Kebreab K   Clayton Gina M GM   Garavito R Michael RM   Marnett Lawrence J LJ  

The Journal of biological chemistry 20140114 10


Oxicams are widely used nonsteroidal anti-inflammatory drugs (NSAIDs), but little is known about the molecular basis of the interaction with their target enzymes, the cyclooxygenases (COX). Isoxicam is a nonselective inhibitor of COX-1 and COX-2 whereas meloxicam displays some selectivity for COX-2. Here we report crystal complexes of COX-2 with isoxicam and meloxicam at 2.0 and 2.45 angstroms, respectively, and a crystal complex of COX-1 with meloxicam at 2.4 angstroms. These structures reveal  ...[more]

Similar Datasets

| S-EPMC5836124 | biostudies-literature
| S-EPMC5018803 | biostudies-literature
| S-EPMC5588449 | biostudies-literature
| S-EPMC3678763 | biostudies-literature
| S-EPMC8750573 | biostudies-literature
| S-EPMC5127262 | biostudies-literature
| S-EPMC2840032 | biostudies-literature
| S-EPMC3975892 | biostudies-literature
| S-EPMC4648280 | biostudies-literature
| S-EPMC3149774 | biostudies-literature